IRIS
GURNARI, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.898
EU - Europa 852
AS - Asia 630
AF - Africa 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.394
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.895
SG - Singapore 425
IT - Italia 416
RU - Federazione Russa 121
IE - Irlanda 116
CN - Cina 93
KR - Corea 83
GB - Regno Unito 71
DE - Germania 41
FI - Finlandia 22
FR - Francia 13
NL - Olanda 11
SE - Svezia 11
IN - India 10
UA - Ucraina 9
JP - Giappone 7
HK - Hong Kong 6
CZ - Repubblica Ceca 5
ES - Italia 5
AT - Austria 3
IR - Iran 3
RO - Romania 3
AR - Argentina 2
AU - Australia 2
BR - Brasile 2
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BY - Bielorussia 1
CA - Canada 1
ID - Indonesia 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
TR - Turchia 1
Totale 4.394
Salva come PNG Salva come JPEG
Città #
Wilmington 655
Houston 596
Singapore 382
Rome 200
Creede 184
Woodbridge 127
Fairfield 121
Dublin 109
Santa Clara 105
Chandler 100
New York 83
Center 63
Ashburn 58
Beijing 48
Seattle 46
Medford 41
Cambridge 37
London 32
Ann Arbor 29
Moscow 25
Council Bluffs 20
Lawrence 20
Milan 18
Dearborn 16
Hackensack 16
Helsinki 14
Boardman 12
Kilburn 11
Seoul 11
Menlo Park 10
Engelhard 9
Mülheim 9
Naples 9
San Diego 9
Guangzhou 8
Pune 8
Bari 7
Lappeenranta 7
Las Vegas 6
Los Angeles 6
Nuremberg 6
Palermo 6
Turin 6
Brno 5
Cormano 5
Marseille 5
Siena 5
Chiswick 4
Florence 4
Hong Kong 4
Jacksonville 4
Paris 4
Parma 4
Redwood City 4
Shanghai 4
Tokyo 4
Amsterdam 3
Bologna 3
Brescia 3
Cerro Tanaro 3
Chicago 3
Cluj-Napoca 3
Hounslow 3
Islington 3
Madrid 3
Marcianise 3
Monterotondo 3
Nanjing 3
Norwalk 3
Pescara 3
Picinisco 3
Sassari 3
Washington 3
Zola Predosa 3
Addis Ababa 2
Apodaca 2
Berlin 2
Cairo 2
Castelnuovo di Val di Cecina 2
Cava de' Tirreni 2
Cipolletti 2
Cleveland 2
Del Norte 2
Desio 2
Durham 2
Ferrara di Monte Baldo 2
Foggia 2
Freiburg im Breisgau 2
Giugliano in Campania 2
Glasgow 2
Guidonia Montecelio 2
Hangzhou 2
Lanciano 2
Las Rozas de Madrid 2
Lecce 2
Messina 2
Morciano di Romagna 2
Mountain View 2
Perugia 2
Prescot 2
Totale 3.447
Salva come PNG Salva come JPEG
Nome #
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia 450
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 298
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes 274
The emerging role of measurable residual disease detection in AML in morphologic remission 248
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia 216
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 183
Immunologia dei trapianti e trapianto di cellule staminali ematopoietiche 171
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 158
Applications and efficiency of flow cytometry for leukemia diagnostics 148
From bench to bedside and beyond: Therapeutic scenario in acute myeloid leukemia 138
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters 95
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 67
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia 65
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression 61
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways 53
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding 53
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy 53
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide 52
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia 52
Have we reached a molecular era in myelodysplastic syndromes? 51
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT 46
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 45
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 44
ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY 43
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML 43
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children? 43
Demethylation and Up-Regulation of an oncogene after hypomethylating therapy 43
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia 41
Germline DDX41 mutations define a unique subtype of myeloid neoplasms 39
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 39
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria 38
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia 37
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design 37
Recurrent Sweet's syndrome in a patient with multiple myeloma 36
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia 33
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes 33
Aplastic anemia: quo vadis? 31
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia 30
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation 29
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations 29
Pegcetacoplan versus Eculizumab in PNH 29
Molecular landscape of immune pressure and escape in aplastic anemia 29
Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough? 28
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience 28
Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia 27
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia 27
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 26
Comprehensive transcriptomic analysis of VISTA in acute myeloid leukemia: insights into its prognostic value 26
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms 26
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes 25
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia 25
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M 25
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics 25
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia 25
Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease 25
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia 24
UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia 24
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria 24
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia 23
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 23
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander? 23
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders 23
Congenital Rhabdomyosarcoma: a different clinical presentation in two cases 23
T-cell large granular lymphocytic leukemia associated with inclusion body myositis 23
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond 22
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes 22
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation 22
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms 22
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies 22
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder 21
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare t-cell lymphoma: a clinical challenge 21
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges 21
STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype 20
The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group 20
Copper Deficiency 19
Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria 18
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood 18
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 18
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia 18
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments 18
Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes 17
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia 17
Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes 17
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria 17
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT 17
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia 17
Alternative Splicing in Myeloid Malignancies 16
How I manage acquired pure red cell aplasia in adults 16
Digging into the HLA pockets: A new association with acute leukaemias 16
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 15
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria 15
Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria 15
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence 15
Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia 14
Novel invariant features of Good syndrome 14
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies 14
Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria 13
Hemolytic versus malproductive anemia in large granular lymphocytic leukemia 13
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept 12
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes 9
Totale 4.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020541 0 0 0 0 45 71 71 67 86 78 62 61
2020/2021731 69 63 84 74 85 86 118 79 19 28 21 5
2021/2022211 6 17 15 5 1 35 9 13 12 14 18 66
2022/20231.172 28 23 13 52 22 62 777 40 33 16 46 60
2023/2024682 92 37 51 45 68 125 73 47 37 36 12 59
2024/2025996 54 498 248 164 32 0 0 0 0 0 0 0
Totale 4.886